A novel role of MNT as a negative regulator of REL and the NF-κB pathway (vol 10, 7, 2021)

被引:1
|
作者
Liano-Pons, Judit
Lafita-Navarro, M. Carmen
Garcia-Gaipo, Lorena
Colomer, Carlota
Rodriguez, Javier
von Kriegsheim, Alex
Hurlin, Peter J.
Ourique, Fabiana
Delgado, M. Dolores
Bigas, Anna
Espinosa, Lluis
Leon, Javier
机构
[1] Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC),Departmento de Biología Molecular
[2] CSIC-Universidad de Cantabria,Cancer Research Program, Institut Hospital del Mar d’Investigacions Mèdiques, CIBERONC
[3] Hospital del Mar,Systems Biology Ireland
[4] University College Dublin,Shriners Hospitals for Children Research Center, Department of Cell, Developmental and Cancer Biology and Department of Orthopaedics and Rehabilitation
[5] Oregon Health and Science University,Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum B7
[6] Karolinska Institutet,Edinburgh Cancer Research Center, Institute of Genetics and Molecular Medicine
[7] Department of Cell Biology UT Southwestern Medical Center,Dept. of Biochemistry
[8] University of Edinburgh,undefined
[9] Universidade Federal de Santa Catarina (UFSC),undefined
关键词
D O I
10.1038/s41389-021-00346-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A novel role of MNT as a negative regulator of REL and the NF-κB pathway
    Liano-Pons, Judit
    Carmen Lafita-Navarro, M.
    Garcia-Gaipo, Lorena
    Colomer, Carlota
    Rodriguez, Javier
    von Kriegsheim, Alex
    Hurlin, Peter J.
    Ourique, Fabiana
    Dolores Delgado, M.
    Bigas, Anna
    Lluis Espinosa, M.
    Leon, Javier
    ONCOGENESIS, 2021, 10 (01)
  • [2] A novel role of MNT as a negative regulator of REL and the NF-κB pathway
    Judit Liaño-Pons
    M. Carmen Lafita-Navarro
    Lorena García-Gaipo
    Carlota Colomer
    Javier Rodríguez
    Alex von Kriegsheim
    Peter J. Hurlin
    Fabiana Ourique
    M. Dolores Delgado
    Anna Bigas
    Lluis Espinosa
    Javier León
    Oncogenesis, 10
  • [3] Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathway
    Judit Liaño-Pons
    M. Carmen Lafita-Navarro
    Lorena García-Gaipo
    Carlota Colomer
    Javier Rodríguez
    Alex von Kriegsheim
    Peter J. Hurlin
    Fabiana Ourique
    M. Dolores Delgado
    Anna Bigas
    Lluis Espinosa
    Javier León
    Oncogenesis, 10
  • [4] NF-κB is essential for induction of CYLD, the negative regulator of NF-κB -: Evidence for a novel inducible autoregulatory feedback pathway
    Jono, H
    Lim, JH
    Chen, LF
    Xu, HD
    Trompouki, E
    Pan, ZXK
    Mosialos, G
    Li, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) : 36171 - 36174
  • [5] To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
    Kucharczak, J
    Simmons, MJ
    Fan, YJ
    Gélinas, C
    ONCOGENE, 2003, 22 (56) : 8961 - 8982
  • [6] To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
    Kucharczak, J
    Simmons, MJ
    Fan, YJ
    Gélinas, C
    ONCOGENE, 2004, 23 (54) : 8858 - 8858
  • [7] To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
    Jérôme Kucharczak
    Matthew J Simmons
    Yongjun Fan
    Céline Gélinas
    Oncogene, 2003, 22 : 8961 - 8982
  • [8] Erratum: To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
    Jérôme Kucharczak
    Matthew J Simmons
    Yongjun Fan
    Céline Gélinas
    Oncogene, 2004, 23 : 8858 - 8858
  • [9] The Rel/NF-κB signal transduction pathway: introduction
    Thomas D Gilmore
    Oncogene, 1999, 18 : 6842 - 6844
  • [10] The Rel/NF-κB signal transduction pathway:: introduction
    Gilmore, TD
    ONCOGENE, 1999, 18 (49) : 6842 - 6844